Comutations in tumor suppressor genes such as TP53, RB1, LKB1 or BRCA1/2 have been described as manifestations of early clonal selection in up to 50% of cases of NSCLC harboring driver mutations, especially in EGFR-mutated tumors [24]. This evidence concerns the gene STK11 and non-small cell lung carcinoma.